HIV vaccines may 'harm' patients

HIV vaccines being developed may do patients more harm than good, studies in mice suggest.

The latest findings strengthen concerns that the adenoviruses being used in some experimental HIV vaccines could speed up T-cell exhaustion.

This would mean a HIV-positive patient would progress more rapidly to AIDS.

Recombinant adeno-associated viruses (rAAV) have been used as vectors to carry selected elements of the HIV-1 virus and act as a vaccine. The latest research could explain why clinical trials into such vaccines have so far led to disappointing results.

It focused on rAAV vectors of different serotypes, all of which expressed HIV-1 gag proteins - essential for virus replication.

The vaccines were injected into female mice, which received a primer and a booster injection one to two months later.

Follow-up assays on immune response demonstrated that CD8+ T cells produced in response to the vaccine poorly protected from infection in a challenge model.

They also proliferated poorly when they came into contact with their antigen.

Additionally, only low levels of the cytokine interferon-gamma were produced in response to gag stimulation.

If an rAAV-vector vaccine against HIV dampens immune response in this way, it could increase the recipient's susceptibility to AIDS by removing their natural immune defences, say the study authors.

Lead researcher Dr Hildegund Ertl, from the Wistar Institute Vaccine Center in Philadelphia, said: 'The results mean that rAAV vaccines against HIV may cause harm and that, without additional preclinical studies, they should not be used in humans.'

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

First COVID-19 jabs to target care home residents and staff under new JCVI advice

First COVID-19 jabs to target care home residents and staff under new JCVI advice

Older adults living in care homes and staff working there will be first to receive...

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs facing fitness to practise investigations during the COVID-19 pandemic will be...

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

A government review has rejected calls for a major overhaul of an NHS Property Services...

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

The RCGP and the Royal Pharmaceutical Society have called on GP practices and community...

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments have risen rapidly in recent weeks as schools returned, according...

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

Medical training and the future NHS workforce could be seriously damaged by the financial...